Leave Your Message
Cinchocaine Base Powder CAS 73-78-9 - Local Anesthetic from Trusted China Suppliers and Factory
Hot Products

Cinchocaine Base Powder CAS 73-78-9 - Local Anesthetic from Trusted China Suppliers and Factory

Physical Characteristics and Specifications of Cinchocaine

,

Product Name: Cinchocaine

,

CAS Number: 73-78-9

,

Molecular Formula: C20H29N3O2

,

Molecular Weight: 343.46

,

EINECS Number: 201-632-1

,

Cinchocaine is a well-known chemical used for its local anesthetic properties. Sourced from reliable China suppliers, our Cinchocaine is produced in our state-of-the-art factory that adheres to strict quality control standards. Renowned for its efficacy and safety, Cinchocaine is essential in various medical applications. Whether you're a manufacturer or a researcher, our high-quality product ensures optimal performance for your needs. Trust our China factory for superior Cinchocaine, a preferred choice among industry professionals.

    Definition

    ChEBI: A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.

    Manufacturing Process

    A benzene solution of 2.2 parts of α-chloro-γ-quinoline-carboxylic acid chloride is gradually mixed, while cooling, with 2.3 parts of unsymmetrical diethylethylenediamine. When the reaction is at an end the solution is washed with water and the new base extracted by means of hydrochloric acid. The base is precipitated by means of sodium carbonate and extracted with benzene. The solvent is distilled and the base recrystallized from petroleum ether. The α-chloro-γ-quinoline-carboxylic acid diethyl-amino-ethylene amide forms colorless lamina crystals of melting point 74°C. With acids the base forms neutral salts soluble in water.

    A solution of 2.5 parts of sodium in n-butylalcohol is boiled with 30 parts of α- chloro-γ-quinoline-carboxylic acid diethyl-amino-ethylene-amide in a reflux apparatus, and when the reaction is over the excess of butylalcohol is distilled. The remaining base is taken up with ether; the solution is washed with water and dried. The solvent is then distilled. The α-n-butoxy-γ-quinoline. carboxylic acid diethyl-amino-ethylene-amide forms as colorless crystals, after recrystallization from petroleum ether melting point of it 64°C.

    In practice it is usually used as hydrochloride.

    General Description

    Articaine has a secondary nitrogen with a pKa of 7.8. It contains an aromatic thiophene ring bioisostere of the phenyl ring found in most other amide anesthetics. The log P of a benzene ring is 2.13 and the thiophene ring log P is 1.81, thus the thiophene ring is more hydrophilic than a phenyl ring. Although the thiophene ring has less lipid solubility than a phenyl ring, articaine is a lipid-soluble compound due to the propylamine, the branched methyl and the substitutions on the thiophene ring. The onset of action of articaine is similar to lidocaine’s onset of action.

    Solubility Tips
    HCl soluble in water, base insoluble in water. (Some Base dissolves in hot water!)

    Clinical Use

    Articaine is available in a 4% solution with epinephrine for use in infiltration and nerve block anesthesia. Articaine is metabolized rapidly via plasma and tissue carboxyesterase to its primary metabolite, the inactive, water-soluble carboxylic acid. Approximately 40% to 70% of articaine administered epidurally is metabolized to the carboxylic acid, articainic acid. Approximately 4% to 15% of the articainic acid undergoes glucuronide conjugation and only 3% of the dose is recovered unchanged in the urine. The rapid plasma metabolism and reported inactivity of the carboxylic acid metabolite make articaine a potentially safer anesthetic agent when multiple or large doses are necessary.

    Uses

    Cinchocaine is a local anesthetic, used for Na+ channel blocker.

    Anesthesia Strength Analysis

    Local anesthesia strength: the anesthesia effect of some base is stronger than hcl.

    Tetracaine > Lidocaine > Benzocaine > Procaine

    Details

    Frequently Asked Questions (FAQs)

    What is Cinchocaine and how is it clinically used?
    Cinchocaine is a potent and toxic long-acting local anesthetic that acts as a Na+ channel blocker. While its parenteral use was restricted to spinal anesthesia, it is now commonly used in creams, ointments, and suppositories to relieve pain and itching from skin and anorectal conditions.
    What are the solubility differences between anesthetic bases and their HCl salts?
    Generally, local anesthetic hydrochloride (HCl) salts are soluble in water, whereas their free base forms are insoluble in water. However, some anesthetic bases can dissolve in hot water.
    Why is Articaine considered a lipid-soluble compound despite having a hydrophilic thiophene ring?
    Although Articaine contains a thiophene ring that is more hydrophilic than a phenyl ring, it remains lipid-soluble due to its specific chemical structure, which includes propylamine, a branched methyl group, and substitutions on the thiophene ring.
    How is Articaine metabolized in the body?
    Articaine is rapidly metabolized via plasma and tissue carboxyesterase into its inactive, water-soluble metabolite, articainic acid. About 40% to 70% of epidurally administered articaine is metabolized this way, with 4% to 15% undergoing glucuronide conjugation and only 3% excreted unchanged in urine.
    What is the strength order of common local anesthetics?
    The general local anesthesia strength hierarchy is Tetracaine > Lidocaine > Benzocaine > Procaine. Additionally, the anesthetic effect of some free bases is stronger than their HCl salt forms.